Aptose Biosciences
APTO
#10464
Rank
A$6.58 M
Marketcap
A$2.58
Share price
0.00%
Change (1 day)
725.55%
Change (1 year)

Aptose Biosciences (APTO) - Total liabilities

Total liabilities on the balance sheet as of March 2025 : A$22.41 Million

According to Aptose Biosciences's latest financial reports the company's total liabilities are A$22.41 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Aptose Biosciences - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2023-12-31A$23.32 M19.46%
2022-12-31A$19.52 M70.76%
2021-12-31A$11.43 M19.66%
2020-12-31A$9.55 M2.13%
2019-12-31A$9.35 M136.3%
2018-12-31A$3.95 M75.12%
2017-12-31A$2.26 M23.64%
2016-12-31A$1.82 M-21.74%
2015-12-31A$2.33 M
2014-05-31A$2.43 M33.71%
2013-05-31A$1.82 M-32.3%
2012-05-31A$2.69 M142.31%
2011-05-31A$1.11 M-65.68%
2010-05-31A$3.23 M-82%
2009-05-31A$17.97 M10.42%
2008-05-31A$16.27 M0.97%
2007-05-31A$16.12 M-5.28%
2006-05-31A$17.02 M13.69%
2005-05-31A$14.97 M150.06%
2004-05-31A$5.98 M-0.1%
2003-05-31A$5.99 M50.42%
2002-05-31A$3.98 M-46.42%
2001-05-31A$7.43 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Advaxis
ADXS
A$61.85 M 175.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Corbus Pharmaceuticals
CRBP
A$21.26 M-5.15%๐Ÿ‡บ๐Ÿ‡ธ USA
ImmunoGen
IMGN
A$0.39 B 1,653.06%๐Ÿ‡บ๐Ÿ‡ธ USA